Position in PFE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$219,850
-$36,520 QoQ
Shares Held
9,130
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#2,386
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026KELLY LAWRENCE W & ASSOCIATES INC/CA holds $15,835,572 across 7 Drug Manufacturers - General names. PFE ranks #6 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
47,610 | $12,091,511 | |
| 2 | ABBV |
AbbVie Inc.
|
7,791 | $1,960,527 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
6,044 | $763,598 | |
| 4 | AMGN |
Amgen Inc
|
1,398 | $506,243 | |
| 5 | LLY |
ELI LILLY & Co
|
227 | $272,270 | |
| 6 | PFE |
Pfizer Inc
This page
|
9,130 | $219,850 | |
| 7 | NVO |
Novo Nordisk A S
|
450 | $21,573 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $219,850 | 9,130 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $256,370 | 9,130 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $227,337 | 9,130 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $232,632 | 9,130 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $221,311 | 9,130 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $231,354 | 9,130 | Shares | Other | 2025-05-14 | |
| 2024-12-31 | $242,218 | 9,130 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $293,162 | 10,130 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $283,437 | 10,130 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $253,357 | 9,130 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $262,852 | 9,130 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $543,092 | 16,373 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $635,407 | 17,323 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $719,018 | 17,623 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $903,002 | 17,623 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $771,181 | 17,623 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $923,972 | 17,623 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,027,530 | 19,848 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,301,933 | 22,048 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $914,306 | 21,258 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $832,462 | 21,258 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $770,176 | 21,258 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $227,485 | 6,180 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $793,085 | 21,610 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $706,647 | 21,610 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $710,244 | 21,760 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||